Severe granulocytopenia in a patient on long-term use of clozapine and with COVID-19
Psychiatry Res
.
2021 Nov:305:114171.
doi: 10.1016/j.psychres.2021.114171.
Epub 2021 Aug 14.
Authors
Victoria de Carvalho Pereira
1
,
Douglas Zucolotto de Stefani
2
,
Arthur Gomes Oliveira Braga
3
,
Jennyfer Fernanda Rodrigues Domingues
2
,
Amilton Dos Santos-Junior
4
,
Paulo Dalgalarrondo
5
,
Cláudio E M Banzato
6
Affiliations
1
Department of Psychiatry, Medical School, University of Campinas (Unicamp), Campinas, SP, Brazil.. Electronic address:
[email protected]
.
2
Department of Psychiatry, Medical School, University of Campinas (Unicamp), Campinas, SP, Brazil.
3
Department of Internal Medicine - Division of Hematology, Medical School, University of Campinas (Unicamp), Campinas, SP, Brazil.
4
Department of Psychiatry, Medical School, University of Campinas (Unicamp), Campinas, SP, Brazil.. Electronic address:
[email protected]
.
5
Department of Psychiatry, Medical School, University of Campinas (Unicamp), Campinas, SP, Brazil.. Electronic address:
[email protected]
.
6
Department of Psychiatry, Medical School, University of Campinas (Unicamp), Campinas, SP, Brazil.. Electronic address:
[email protected]
.
PMID:
34433120
PMCID:
PMC8364139
DOI:
10.1016/j.psychres.2021.114171
No abstract available
Publication types
Letter
MeSH terms
Agranulocytosis* / chemically induced
Antipsychotic Agents* / adverse effects
COVID-19*
Clozapine* / adverse effects
Humans
SARS-CoV-2
Substances
Antipsychotic Agents
Clozapine